ReiThera srl is a biotech company developing products based on gene delivery technologies for advanced therapies, from early development to final QP release.

ReiThera’s management and scientific teams have successfully developed genetic vaccines against major infectious diseases, including hepatitis C, malaria, HIV, Respiratory Syncytial Virus and Ebola using the highly innovative chimpanzee-derived adenovirus (ChAd) platform within Okairos, a company founded by Prof. Riccardo Cortese, Alfredo Nicosia, Antonella Folgori and Stefano Colloca.